Deborah Mash: Unveiling Ibogaine's Role in Addiction Treatment
Ibogaine has never completed clinical trials anywhere in the world.
Have you ever heard of ibogaine and wondered if it could really help with addiction? In this episode of Harm Reduction Radio - HAMS, host Kenneth Anderson sits down with Dr. Deborah Mash, a leading expert and Professor of Neurology and Molecular and Cellular Pharmacology at the University of Miami. They dive into the intriguing world of ibogaine, a substance derived from the iboga plant, known for its hallucinogenic properties and its traditional use in African religious rituals. Dr.
Mash shares her extensive research on ibogaine's potential as a treatment for heroin and other addictions. She sheds light on the safety concerns, the efficacy of the substance, and the hurdles faced in conducting clinical trials. Despite ibogaine never completing clinical trials globally, Dr. Mash's insights offer a fascinating glimpse into its promise as a harm reduction tool. The conversation doesn't stop at ibogaine. Dr.
Mash and Anderson also discuss other harm reduction treatments and emphasize the importance of professional help for those battling addiction. This episode is a must-listen for anyone curious about innovative approaches to addiction treatment and the ongoing quest for effective solutions. Tune in to hear Dr. Mash's expert perspective on ibogaine and its place in the evolving landscape of addiction recovery.